DHX33 and cancer: DHX33 is required for promoting cell cycle progression at the G1-to-S phase transition, which is overexpressed in several types of human cancers, such as lung cancers, hepatocellular carcinoma, lymphoma, colon cancer, and glioblastoma (Table 1) [16,51,52,53,54].